Mark A. Green

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

Charles Butts, Keyue Ding, Lesley Seymour et al. · Journal of Clinical Oncology · 2009 · 421 citations · Full text

Synthesis, Purification, and Tumor Cell Uptake of ⁶⁷Ga-Deferoxamine−Folate, a Potential Radiopharmaceutical for Tumor Imaging

Susan Wang, Robert J. Lee, Carla J. Mathias et al. · Bioconjugate Chemistry · 1996 · 241 citations

Design and Synthesis of [¹¹¹In]DTPA−Folate for Use as a Tumor-Targeted Radiopharmaceutical

Susan Wang, Jin Luo, Douglas A. Lantrip et al. · Bioconjugate Chemistry · 1997 · 202 citations

Engineering, Tumor Biology, Medicinal Chemistry +17

Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.

Noah C. Choi, James E. Herndon, Julian Rosenman et al. · Journal of Clinical Oncology · 1998 · 197 citations

Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma

Patrick J. Loehrer, Michael R. Jiroutek, Seena C. Aisner et al. · Cancer · 2001 · 186 citations